Drug intelligence / Profile preview

Sapugel

Development stage
Preclinical
Lead developer
Chongqing Fujin Biological Medicine
Modality
Peptides
Administration
Topical
01

Overview

Sapugel is a topical self-assembling peptide hydrogel developed by Chongqing Fujin Biomedical (Fagen Bio). It is composed of the RADA16 peptide, which spontaneously organizes into a stable, three-dimensional nanofiber scaffold upon contact with physiological fluids or electrolytes. This hydrogel acts as a biomimetic extracellular matrix, providing a protective physical barrier and a structural environment that promotes cell migration and tissue regeneration. Sapugel is intended for the management of various wounds, including pressure ulcers, leg ulcers, diabetic ulcers (including diabetic foot ulcers), surgical wounds, and skin abrasions or burns associated with dermabrasion and laser resurfacing. The product is currently in preclinical development, having completed biocompatibility and transdermal absorption studies.

Brand names
Sapugel
Other names
RADA16-based self-assembling peptide hydrogelRADA-16-based self-assembling peptide hydrogelRADA 16-based self-assembling peptide hydrogel

Beyond the preview

Go deeper on Sapugel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sapugel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call